PG
The Procter & Gamble Company
Updated 2026-05-07
The Procter & Gamble Company (PG) Stock Price, Analysis & Forecast 2026
$146.42 ▲ 0.25%
PG interactive stock chart
Key statistics
8.3/10
7.1/10
10/10
5.1/10
5.4/10
| Market cap | $342.84B | Today’s volume | 24,158 |
| Revenue (TTM) | $84.28B | Avg. daily volume | N/A |
| P/E ratio | 21.31x | Today’s range | 146.4 – 147.99 |
| Debt / equity | 0.68x | 52-week range | 137.62-170.99 |
| Net margin | 19.22% | Beta | 0.398x |
| ROE | N/A% | Current ratio | 0.73x |
| Dividend & yield | $4.2594 (0.03%) | Next earnings | 2026-08-04 |
| FCF yield | 4.39% | FMP rating | A- |
| DCF fair value | $225.17 (52.9%) | Revenue growth | 0.3% |
See also: CL · CLX · COST · EPC · KMB · All Household & Personal Products stocks
Is PG a good stock to buy in 2026?
The Procter & Gamble Company (PG) presents a mixed signal for investors in 2026. While its P/E ratio of 21.31x is slightly above the Household & Personal Products sector average of 20x, its Discounted Cash Flow (DCF) model suggests a fair value of $225.17, indicating it is currently undervalued by 52.9%. Furthermore, a strong consensus with 53.8% analyst buy ratings points towards positive sentiment for PG stock, suggesting it could be a cautious buy for long-term investors.
✗ Slowing Revenue Growth
– Cautious Buy Signal
2026 PG price scenarios
Based on analyst consensus of $161.88 from 52 analysts. Not a prediction by Alert Invest.
Key risks:
- Intensified competition leading to market share erosion and pricing pressures on key brands.
- Significant disruptions in global supply chains or a sustained increase in raw material costs, compressing already tight margins.
- A broader economic downturn resulting in weaker-than-expected consumer spending for discretionary household and personal care products.
Assumes:
- PG effectively leverages its robust brand portfolio to maintain stable organic sales, progressing towards its forward revenue estimate of $100.1B.
- The company continues to implement cost-saving initiatives and maintains pricing power, supporting a forward EPS of $8.40237.
- Procter & Gamble’s consistent dividend policy remains attractive to long-term income investors, providing a floor for the PG stock price.
Requires:
- Breakthrough innovation or successful new product launches that significantly accelerate market share gains and revenue growth beyond current modest projections.
- Greater-than-expected effectiveness of premiumization strategies or aggressive cost efficiencies that lead to a notable expansion in profit margins.
- A stronger-than-anticipated global economic recovery, boosting consumer confidence and spending across all of P&G’s product categories.
How does PG compare?
Side-by-side valuation, growth, and analyst ratings vs top Consumer Defensive competitors.
About The Procter & Gamble Company (PG)
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Led by CEO Shailesh G. Jejurikar, Procter & Gamble employs approximately 108,000 individuals globally, leveraging its extensive workforce to manage a vast portfolio of trusted household and personal care brands. The company’s distinctive strengths lie in its unparalleled brand recognition, global distribution network, and a long history of product innovation, which together foster deep consumer loyalty and resilience in various economic climates.
PG competitive moat and business analysis
Procter & Gamble’s competitive advantage is largely derived from its massive scale, brand equity, and extensive distribution capabilities. With a net margin of 19.22% and a gross margin of 50.33%, the company demonstrates strong profitability in the highly competitive consumer defensive sector. While specific ROE/ROIC data is not available, these robust margins suggest efficient operations and a strong ability to convert sales into profit, a hallmark of companies with significant economic moats. This allows PG stock to maintain consistent performance even during challenging periods.
The provided data for fiscal year 2025 does not include a specific breakdown of revenue by segments or geographical regions. However, P&G’s diversified product portfolio, spanning beauty, grooming, healthcare, fabric & home care, and baby, feminine & family care, inherently provides resilience. Its global presence also mitigates risks associated with over-reliance on any single market.
Despite its robust competitive moat, P&G’s revenue growth has been modest at +0.3% year-over-year. This reflects the mature nature of many of its markets and the sheer size of the company. The moat’s trend is focused more on maintaining stability and profitability rather than rapid top-line expansion, which is typical for established consumer staples giants. Investors in PG stock often prioritize consistent dividends and defensive characteristics over aggressive growth.
When comparing Procter & Gamble to its peers like Colgate-Palmolive (CL), The Clorox Company (CLX), and Costco Wholesale (COST), PG generally stands out due to the sheer breadth and depth of its brand portfolio. While peers may excel in specific niches, P&G’s comprehensive market presence and diversification across multiple household product categories provide a broader revenue base and arguably greater long-term stability for PG stock holders.
The Procter & Gamble Company analyst rating
Based on 52 analysts. 53.8% rate PG Buy or Strong Buy.
Buy53.8%
Hold44.2%
Sell1.9%
A 53.8% buy rating for PG stock is generally considered a strong endorsement, particularly for a mature, defensive sector company like Procter & Gamble. While less volatile stocks might often gather more “Hold” ratings, a majority “Buy” suggests analysts see significant upside potential or consistent stability that makes it an attractive investment.
PG financial scorecard
Comprehensive ranking of PG across four financial dimensions.
6.0/10
| Metric | Value | Signal & strength |
|---|---|---|
| Debt / equity | 0.68x | Moderate |
| Current ratio | 0.73x | Tight |
| FCF yield | 4.39% | Fair |
| DCF vs price | +52.9% | Undervalued |
| FMP debt score | 2/5 | Below avg |
10/10
| Metric | Value | Signal & strength |
|---|---|---|
| Gross margin | 50.33% | Excellent |
| Net margin | 19.22% | Good |
| EBITDA margin | 26.82% | Good |
| ROE | N/A | Low |
| ROA | N/A | Low |
| FMP ROE score | 5/5 | Above avg |
4.1/10
| Metric | Value | Signal & strength |
|---|---|---|
| Revenue growth YoY | +0.3% | Slowing |
| Revenue (TTM) | $84.28B | Large scale |
| Forward EPS est. | $8.40237 | Analyst consensus |
| Forward revenue | $100.1B | Analyst consensus |
| FMP DCF score | 4/5 | Above avg |
4.0/10
| Metric | Value | Signal & strength |
|---|---|---|
| P/E ratio | 21.31x | Fair |
| P/B ratio | 6.52x | Expensive |
| P/S ratio | 3.95x | Fair |
| DCF fair value | $225.17 | Undervalued |
| FMP P/E score | 3/5 | Average |
| FMP overall | 4/5 | Strong |
Is PG undervalued or overvalued?
Fair
Expensive
Fair
Undervalued
Fair
+10.0% upside
The valuation for PG stock presents a somewhat mixed picture, with different metrics suggesting varying conclusions. Its trailing P/E ratio of 21.31x is slightly higher than the Household & Personal Products sector average of 20x, indicating it might be trading at a slight premium compared to its immediate peers. This premium could be justified by its strong brand portfolio and consistent profitability.
However, a Discounted Cash Flow (DCF) analysis reveals a fair value of $225.17, which implies that PG stock is significantly undervalued by 52.9% relative to its current trading price. This substantial difference suggests that, based on future cash flow projections, P&G could offer considerable upside for long-term investors. Other metrics like the P/B ratio at 6.52x appear expensive, while the P/S ratio of 3.95x suggests a fair valuation.
PG financial health & key metrics
| Metric | PG | Sector avg | Signal |
|---|---|---|---|
| P/E ratio | 21.31x | 20x | Fair (Slightly above sector) |
| Net margin | 19.22% | — | Excellent |
| ROE / ROIC | N/A | — | N/A |
| Debt / equity | 0.68x | — | Moderate |
| FCF yield | 4.39% | — | Fair |
| Revenue growth | 0.3% | — | Slowing |
| DCF fair value | $225.17 | — | Undervalued |
For value investors, PG stock demonstrates robust financial health with an excellent net margin of 19.22%, indicating strong operational efficiency and pricing power. While its P/E ratio is slightly above the sector average, the significant undervaluation suggested by its DCF fair value of $225.17 highlights a potential buying opportunity. The moderate debt-to-equity ratio of 0.68x and fair FCF yield of 4.39% further support its stability, despite a modest revenue growth of 0.3%, positioning P&G as a solid defensive investment.
The Procter & Gamble Company earnings history & next report
The Procter & Gamble Company reported EPS of $1.59, beating estimates by 1.92%. Next earnings: 2026-08-04 with EPS estimate of $1.46.
When The Procter & Gamble Company reports its next earnings on 2026-08-04, investors should closely watch for details on organic sales growth across its key segments, particularly in Beauty and Healthcare, as well as any updates to full-year guidance. Any commentary on input cost inflation and pricing strategies will be crucial in understanding how the company plans to maintain its impressive net margins, especially with an EPS estimate of $1.46 for the upcoming quarter.
PG daily short volume
Short volume data from FINRA CNMS Consolidated — shares sold short in the most recent US trading session. A high short ratio can signal bearish conviction or a potential short squeeze. Updated every trading day.
| Metric | Value | Context |
|---|---|---|
| Short volume ratio | 59.8% | 40-60% = moderate |
| Shares sold short | 1.81M | FINRA-reported for 2026-05-06 |
| Total reported volume | 3.02M | All FINRA ATS + OTC volume |
| Exempt short volume | 6.6K | Market-maker / arbitrage exempt trades |
| Signal | Moderate short activity | FINRA CNMS Consolidated |
PG insider trading activity
Corporate insiders must report trades to the SEC within two business days.
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-01 | Gama Paul | Officer: Ceo- Health Care | Sale | 0 | N/A | $0 | SEC |
| 2026-04-01 | Gama Paul | Officer: Ceo- Health Care | Sale | 0 | N/A | $0 | SEC |
| 2026-04-01 | Gama Paul | Officer: Ceo- Health Care | Sale | 58 | N/A | $0 | SEC |
| 2023-02-28 | Gama Paul | Officer: Ceo- Health Care | Sale | 6,807 | $113.23 | $770,757 | SEC |
| 2023-09-29 | Gama Paul | Officer: Ceo- Health Care | Sale | 8,250 | $139.24 | $1,148,730 | SEC |
| 2023-09-15 | Gama Paul | Officer: Ceo- Health Care | Sale | 7,482 | $138.63 | $1,037,230 | SEC |
Source: SEC Form 4 via EDGAR · Data: Financial Modeling Prep · Not investment advice
Recent PG analyst rating changes
| Firm | Previous | New rating | Date | Action | |
|---|---|---|---|---|---|
| UBS | Buy | → | Buy | 2026-04-27 | Reiterated |
| Evercore ISI Group | In Line | → | In Line | 2026-04-27 | Reiterated |
| Wells Fargo | Overweight | → | Overweight | 2026-04-27 | Reiterated |
| TD Cowen | Hold | → | Hold | 2026-04-27 | Reiterated |
| JP Morgan | Overweight | → | Overweight | 2026-04-17 | Reiterated |
The Procter & Gamble Company stock news today
How does PG compare to its peers?
For investors considering PG stock, it’s insightful to compare its standing against other prominent players in the Consumer Defensive sector. While each company has its unique focus, they all vie for consumer spending on essential household and personal care products. Here’s how Procter & Gamble stacks up against some key competitors.
Colgate-Palmolive Company is a global consumer products company focused on oral care, personal care, home care, and pet nutrition. It boasts strong brand recognition in toothpaste and soaps, similar to P&G’s household staples.
The Clorox Company is a manufacturer and marketer of consumer and professional products, primarily focused on cleaning, household, and lifestyle categories. Known for its strong bleach brand, Clorox competes with P&G in specific home care segments.
Costco Wholesale Corporation operates a chain of membership warehouses, offering a wide selection of branded and private-label products at low prices. While a retailer, Costco’s strength in consumer goods distribution makes it an indirect competitor and a key sales channel for companies like P&G.
Alert Invest · Free Newsletter
Get alerts when top investors buy a stock!
Track when institutional investors, insiders, and analysts change their positions. Alert Invest sends you a data-driven brief the moment it happens — free, every week.
- Institutional & insider moves
- Analyst upgrades & downgrades
- 100% free — unsubscribe anytime
FAQ — The Procter & Gamble Company (PG) stock
For informational purposes only. Not investment advice. Data: Financial Modeling Prep & SEC EDGAR. Always do your own research.
